CPC A61K 31/197 (2013.01) [A61J 1/1468 (2015.05); A61J 7/0053 (2013.01); A61K 9/0095 (2013.01); A61K 47/14 (2013.01); A61K 47/26 (2013.01); A61K 47/46 (2013.01)] | 19 Claims |
1. A ready-to-use liquid oral pharmaceutical composition consisting of:
about 0.1 wt % to about 20 wt % of vigabatrin or a pharmaceutically acceptable salt thereof;
about 0.001 wt % to about 1.0 wt % of at least one preservative;
about 0.01 wt % to about 40.0 wt % of at least one sweetening agent;
about 0.001 wt % to about 10.0 wt % of at least one flavoring agent; and
quantum satis (q.s.) purified water;
wherein the composition is stable for at least six months at temperatures ranging from 2° C. to 30° C., and
wherein the total concentration of 5-vinylpyrrolidin-2-one and other impurities is not more than 0.04 wt %.
|